The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Neovacs: Approval for Phase 2b Study with IFNalpha-Kinoid (2015-09-01)
NEOVACS (Alternext Paris: ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, today announced that it has been granted first approvals by regulatory agencies and ethics commitees in several European countries for a Phase IIb clinica...
- LimmaTech Biologics AG Starts Operating (2015-08-28)
LimmaTech Biologics was founded in May 2015. In February 2015, GSK acquired GlycoVaxyn, a clinical stage biopharmaceutical firm focused on the research and development of next-generation bioconjugate vaccines using proprietary technology enabling biological synthes...
- MorphoSys and Immatics Partner in Cancer Immunotherapy (2015-08-25)
Collaboration Aims to Develop Novel Antibody-Based Therapies Targeting Tumor-Associated Peptides Derived From Intracellular Proteins MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and Immatics Biotechnologies GmbH announced today a strategic...
- Oncodrone Receives €2.5 Million Eurostars Grant (2015-08-25)
Oncodrone, the anti-cancer company based in Nijmegen, The Netherlands, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155 for treatment of prostate cancer. The Eurostars grant will enable the Oncodrone to progress OCD155...
- Osthus Partners with Dotmatics to Support Life Sciences R&D (2015-08-24)
Osthus joins forces with Dotmatics The new partnership will allow Osthus to expand its partner portfolio, providing end-users with improved product knowledge in R&D IT environments across life science and other related industries. “Our new alliance will now...
- AZ Appoints Sean Bohen EVP Global Medicines Development (2015-08-24)
AstraZeneca today announced the appointment of Sean Bohen MD, PhD, as Executive Vice President of Global Medicines Development and Chief Medical Officer. He will join the company on 15 September. Dr. Bohen will be responsible for driving the progress of AstraZen...
- Lumora Sells Heat Elution Technology to Roche (2015-08-24)
Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid Heat Elution purification technology1 to Roche. Roche has signed a definitive Asset Purchase Agreement wi...
- GSK to Divest All Rights to Ofatumumab to Novartis (2015-08-21)
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with Novartis Pharma AG (“Novartis Pharma”), a subsidiary of Novartis AG, to divest its rights in ofatumumab for auto-immune indications, including multiple sclerosis. Novartis Pharma previously ac...
- Roche Acquires Microbial Diagnostics Firm GeneWeave (2015-08-20)
GeneWEAVE’s Smarticles technology enhances Roche’s role in fighting drug-resistant bacteria Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has signed a definitive agreement to acquire GeneWEAVE BioSciences, Inc. (GeneWEAVE), a privately held compan...
- Celsus Therapeutics Announces $75m Private Placement (2015-08-18)
Celsus Therapeutics Plc (NASDAQ: CLTX) and Volution Immuno Pharmaceuticals SA today announced that Celsus has entered into a securities purchase agreement for a private placement with a select group of investors, led by Deerfield, and including Venrock, Vivo Capita...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)